|
TINF2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.802200E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.596600E-03 |
| Normal-vs-Stage2 |
4.817900E-03 |
| Normal-vs-Stage3 |
3.831700E-02 |
| Normal-vs-Stage4 |
9.6549999999973E-05 |
| Stage1-vs-Stage2 |
5.713800E-01 |
| Stage1-vs-Stage3 |
8.670800E-01 |
| Stage1-vs-Stage4 |
1.157160E-01 |
| Stage2-vs-Stage3 |
5.486400E-01 |
| Stage2-vs-Stage4 |
8.444300E-02 |
| Stage3-vs-Stage4 |
5.117500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.764700E-04 |
| Normal-vs-AfricanAmerican |
2.558800E-03 |
| Normal-vs-Asian |
3.388000E-02 |
| Caucasian-vs-AfricanAmerican |
9.331000E-01 |
| Caucasian-vs-Asian |
6.229800E-01 |
| AfricanAmerican-vs-Asian |
4.853600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.820300E-04 |
| Normal-vs-Female |
2.411000E-01 |
| Male-vs-Female |
4.172300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.421800E-03 |
| Normal-vs-Extreme_Weight |
2.196800E-03 |
| Normal-vs-Obese |
7.544500E-03 |
| Normal-vs-Extreme_Obese |
1.576610E-03 |
| Normal_Weight-vs-Extreme_Weight |
8.117600E-01 |
| Normal_Weight-vs-Obese |
4.489600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.870600E-01 |
| Extreme_Weight-vs-Obese |
5.462400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.014000E-01 |
| Obese-vs-Extreme_Obese |
1.610400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.504770E-01 |
| Normal-vs-Age(41-60Yrs) |
1.237900E-02 |
| Normal-vs-Age(61-80Yrs) |
7.828800E-04 |
| Normal-vs-Age(81-100Yrs) |
1.716230E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.111800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.806000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.616190E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.470000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.475970E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.226000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.761200E-03 |
| Normal-VS-Type2 PRCC |
1.76121999999612E-05 |
| Normal-VS-KIRP CIMP |
5.090200E-02 |
| Normal-VS-Unclassified PRCC |
2.143800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.578100E-03 |
| Type1 PRCC-VS-KIRP CIMP |
6.780000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.617400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.605200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.195800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.810800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.96860000001298E-06 |
| Normal-vs-N1 |
1.801680E-02 |
| Normal-vs-N2 |
1.015110E-03 |
| N0-vs-N1 |
1.660810E-01 |
| N0-vs-N2 |
1.495990E-01 |
| N1-vs-N2 |
9.950000E-02 |
|
|
